Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+ T Cells of Patients with Relapsing-Remitting Multiple Sclerosis

by Meira, Maria, Sievers, Claudia, Hoffmann, Francine, Rasenack, Maria, Kuhle, Jens, Derfuss, Tobias, Kappos, Ludwig, Lindberg, Raija L. P.
Published 2014

Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development

by Meira, Maria, Sievers, Claudia, Hoffmann, Francine, Haghikia, Aiden, Rasenack, Maria, Décard, Bernhard F., Kuhle, Jens, Derfuss, Tobias, Kappos, Ludwig, Lindberg, Raija L.P.
Published 2016